250 related articles for article (PubMed ID: 18726158)
1. Diagnosis and treatment of mood disorders in adults with developmental disabilities.
Antonacci DJ; Attiah N
Psychiatr Q; 2008 Sep; 79(3):171-92. PubMed ID: 18726158
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and treatment of aggression in individuals with developmental disabilities.
Antonacci DJ; Manuel C; Davis E
Psychiatr Q; 2008 Sep; 79(3):225-47. PubMed ID: 18726157
[TBL] [Abstract][Full Text] [Related]
3. A review of empirical evidence of somatic treatment options for the MI/DD population.
Ulzen TP; Powers RE
Psychiatr Q; 2008 Sep; 79(3):265-73. PubMed ID: 18726159
[TBL] [Abstract][Full Text] [Related]
4. Anxiety disorders in persons with developmental disabilities: empirically informed diagnosis and treatment. Reviews literature on anxiety disorders in DD population with practical take-home messages for the clinician.
Davis E; Saeed SA; Antonacci DJ
Psychiatr Q; 2008 Sep; 79(3):249-63. PubMed ID: 18726156
[TBL] [Abstract][Full Text] [Related]
5. Mood disorders in intellectual disability.
Hurley AD
Curr Opin Psychiatry; 2006 Sep; 19(5):465-9. PubMed ID: 16874117
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation and treatment of development disorder with mood disorder].
Saito T
Seishin Shinkeigaku Zasshi; 2013; 115(6):657-63. PubMed ID: 23944125
[TBL] [Abstract][Full Text] [Related]
7. Developmental level and psychopathology: comparing children with developmental delays to chronological and mental age matched controls.
Caplan B; Neece CL; Baker BL
Res Dev Disabil; 2015 Feb; 37():143-51. PubMed ID: 25498740
[TBL] [Abstract][Full Text] [Related]
8. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
[TBL] [Abstract][Full Text] [Related]
9. [Characteristics of catatonia in schizophrenia and mood disorders].
van den Ameele S; Sabbe B; Morrens M
Tijdschr Psychiatr; 2015; 57(2):94-8. PubMed ID: 25669945
[TBL] [Abstract][Full Text] [Related]
10. Interdisciplinary treatment of encopresis in individuals with developmental disorders: need and efficacy.
Groves JA
Monogr Am Assoc Ment Defic (1982); 1982; (5):279-327. PubMed ID: 6188048
[TBL] [Abstract][Full Text] [Related]
11. The diagnosis and treatment of individuals with mental illness and developmental disabilities: an overview.
Barnhill LJ
Psychiatr Q; 2008 Sep; 79(3):157-70. PubMed ID: 18766442
[TBL] [Abstract][Full Text] [Related]
12. The 2020 Royal Australian and New Zealand College of psychiatrists clinical practice guidelines for mood disorders: Bipolar disorder summary.
Malhi GS; Bell E; Boyce P; Bassett D; Berk M; Bryant R; Gitlin M; Hamilton A; Hazell P; Hopwood M; Lyndon B; McIntyre RS; Morris G; Mulder R; Porter R; Singh AB; Yatham LN; Young A; Murray G
Bipolar Disord; 2020 Dec; 22(8):805-821. PubMed ID: 33296123
[TBL] [Abstract][Full Text] [Related]
13. Electroconvulsive Therapy for the Treatment of Severe Mood Disorders During Adolescence: A Retrospective Chart Review.
Ghaziuddin N; Shamseddeen W; Gettys G; Ghaziuddin M
J Child Adolesc Psychopharmacol; 2020 May; 30(4):235-243. PubMed ID: 32125885
[No Abstract] [Full Text] [Related]
14. Use of herbal medicine in primary care patients with mood and anxiety disorders.
Roy-Byrne PP; Bystritsky A; Russo J; Craske MG; Sherbourne CD; Stein MB
Psychosomatics; 2005; 46(2):117-22. PubMed ID: 15774949
[TBL] [Abstract][Full Text] [Related]
15. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone.
Aman MG; Gharabawi GM;
J Clin Psychiatry; 2004 Sep; 65(9):1197-210. PubMed ID: 15367046
[TBL] [Abstract][Full Text] [Related]
16. Psychotropic medication use in people with developmental disabilities.
Curtis JL
Md Med J; 1997 Oct; 46(9):481-5. PubMed ID: 9327650
[TBL] [Abstract][Full Text] [Related]
17. Assessing unipolar mood disorders in women.
Yonkers KA
Psychopharmacol Bull; 1998; 34(3):261-6. PubMed ID: 9803751
[TBL] [Abstract][Full Text] [Related]
18. Under-recognition and under-treatment of DSM-IV classified mood and anxiety disorders among disability claimants.
Cornelius B; van der Klink JJ; Brouwer S; Groothoff JW
Disabil Rehabil; 2014; 36(14):1161-8. PubMed ID: 24024541
[TBL] [Abstract][Full Text] [Related]
19. Individualized continuation electroconvulsive therapy and medication as a bridge to relapse prevention after an index course of electroconvulsive therapy in severe mood disorders: a naturalistic 3-year cohort study.
Odeberg H; Rodriguez-Silva B; Salander P; Mårtensson B
J ECT; 2008 Sep; 24(3):183-90. PubMed ID: 18695624
[TBL] [Abstract][Full Text] [Related]
20. Treatment of anxiety disorders in the Finnish general population.
Sihvo S; Hämäläinen J; Kiviruusu O; Pirkola S; Isometsä E
J Affect Disord; 2006 Nov; 96(1-2):31-8. PubMed ID: 16797721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
